Apolipoprotein L Domain Containing 1 (APOLD1) (C-Term) Peptide
APOLD1
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN2183642
Quick Overview for Apolipoprotein L Domain Containing 1 (APOLD1) (C-Term) Peptide (ABIN2183642)
Target
APOLD1
(Apolipoprotein L Domain Containing 1 (APOLD1))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- C-Term
-
Sequence
- AKIQKLAESL ESCTGALDEL SEQLESRVQL CTKSSRGHDL KISADQRAGL
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-APOLD1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeat freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- APOLD1 (Apolipoprotein L Domain Containing 1 (APOLD1))
-
Background
-
APOLD1 is an endothelial cell early response protein that may play a role in regulation of endothelial cell signaling and vascular function.
Alias Symbols: VERGE
Protein Size: 248 -
Molecular Weight
- 27 kDa
-
Gene ID
- 81575
-
NCBI Accession
- NM_030817, NP_110444
Target
-
You are here:
